throbber
Peptides
`
`The Wave of the Future
`
`Proceedings of the Second International
`and the Seventeenth American
`Peptide Symposium
`
`Edited by
`
`Michal Lebl
`and

`Richard A. Houghten
`
`American Peptide Society
`
`MSN Exhibit 1022 - Page 1 of 4
`MSNv.Bausch - IPR2023-00016
`
`

`

`A C.LP. Catalogue record for this book is available from the Library of Congress.
`
`ISBN 0-9715560-0-8 (American Peptide Society)
`ISBN 1-4020-0473-7 (Kluwer)
`
`Published by American Peptide Society,
`c/o Torrey Pines Institute of Molecular Studies
`3550 General Atomics Court
`San Diego, CA 92121, U.S.A.
`
`Sold and distributed by American Peptide Society
`c/o Torrey Pines Institute of Molecular Studies
`3550 General Atomics Court
`San Diego, CA 92121, U.S.A.
`
`and by Kluwer Academic Publishers
`101 Philip Drive, Norwell, MA 02061, U.S.A.
`(in North, Central and South America)
`P.O. Box 322, 3300 AH Dordrecht,
`The Netherlands
`(in all other countries)
`
`Steenbock Memoria! Library
`University of Wisconsin - Madison
`550 Babcock Drive
`Madison, WI 53706-1293
`
`Copyright ©2001 by American Peptide Society
`
`a
`
`All Rights Reserved. No part of the material protected by this copyright notice may be
`reproduced or utilized in any form or by any means, electronic or mechanical,
`including photocopying, recording or by any information storage andretrieval system,
`without written permission from the copyright owner.
`
`.
`Printed in the Czech Republic
`General Library System
`University of Wisconsin - Madison
`728 State Street
`Madison, WI 83706-1494
`U.S.A.
`
`MSNExhibit 1022 - Page 2 of 4
`MSNv. Bausch - IPR2023-00016
`
`

`

`Peptides: The Wave of the Future
`Michal Lebl and Richard A. Houghten (Editors)
`American Peptide Society, 200]
`
`Systematic Investigation of the Aspartimide Problem
`M.Mergler,F. Dick, B. Sax, P. Weiler and T. Vorherr
`BACHEMAG, CH-4416 Bubendorf, Switzeriand
`
`Introduction
`Aspartimide formation is one of the best-documented side reactions in peptide synthe-
`sis. Even bulky side-chain protecting groups such as OtBu do not prevent this unde-
`sired reaction. In Fmoc/tBu-based SPPS, the repetitive piperidine treatments needed
`for Fmoc removal lead to aspartimide formation and further by-products. Since the
`combination Asp-Gly represents
`the worst-case scenario,
`the hexapeptide
`Val-Lys-Asp-Gly-Tyr-Ile (I) [1] was used in the present work to investigate parame-
`ters influencing aspartimide formation (Fmoc-cleavage conditions, nature of Asp side
`chain protection). Based on the idea of backbone-protection [2], Fmoc-Asp(OtBu)-
`(Hmb)-Gly-OH wasalso synthesised and included in this study.
`Results and Discussion
`For Asp side chain protection, the following groups were applied for synthesis of I as
`their Fmoc-derivatives: OtBu, B-3-methylpent-3-yl ester (OMpe) [3], 4-pyridyl-
`diphenyl-methyl ester (OPyBzh) [4], the bicyclic ortho-ester 4-methyl-2,6,7-trioxa-
`bicyclo-[2,2,2]-octane (OBO) [4] and, as already mentioned, the combination OtBu
`side chain protection plus Hmb-backboneprotection. In the first step, several potential
`by-products, VKdGYI, VKd(GYI), VKD(GYD, VKD(piperidide)GYI
`and
`VKD(GYI)-piperidide, resulting from the opening of the aspartimide cycle, were inde-
`pendently synthesized, Furthermore, RP-HPLC-optimization of these potential con-
`taminants was carried out to properly resolve and quantify the different side products.
`The OPyBzh-protecting group had ideal TFAlability. Unfortunately, high levels of
`aspartimide and piperidides were detected following synthesis of I. Another new de-
`rivative, the orthoester protected Asp derivative (OBO-protection), was designed to
`completely suppress nucleophilic attack at
`the B-carboxy group. Surprisingly,
`@-piperidide was generated during synthesis and, in addition, large quantities of
`aspartimide were observed during the second stage of OBO removal, which consists
`of the saponification under basic conditions. Therefore, the disappointing results ob-
`tained on OPyBzh- and OBO-protection were not included in Table1.
`Table 1. HPLC-analysis ofcrude products (Bakerbond C18 300 A, Phosphate buffer pH 2.3,
`CH3CN as modifier).
`Protection
`Base*
`Product
`D/L-Aspartimide
`L-a-Piperidide
`L-B-Piperidide
`(%)
`(%)
`(%)
`(%)
`89.1
`3.0
`1.5
`<0.3°
`Pip.
`OrwBu
`93.9
`07
`<0.3°
`<0.3°
`Pip.
`OMpe
`94.0
`<0.3°
`<0.3°
`<0.3°
`Pip.
`OtBu/Hmb
`52.4
`218
`9.4
`0.6
`DBU
`OwWu
`83.0
`18
`19
`<0.3>
`DBU
`OMpe
`94.1
`<0.3°
`<0,3°
`<0,3°
`DBU
`OtBu/Hmb
`9 Pip.: Piperidine/DMF 1:4, DBU: DBU/Piperidine/DMF 1 : 20 : 79; > below detection
`limit.
`
`-
`
`63
`
`MSN Exhibit 1022 - Page 3 of 4
`MSNv. Bausch - IPR2023-00016
`
`

`

`Mergler et al.
`
`Two Fmoc-cleavage procedures, the standard protocol piperidine/DMF (1 : 4) and
`1% DBU in piperidine/DMF(1 : 4), and different protecting groups for the Aspresi-
`due in model peptide I (see Table 1) were employed to study aspartimide formation.
`Peptide I, synthesized according to the various strategies indicated above, was ob-
`tained after TFA assisted cleavage, and the crude products were subsequently ana-
`lysed by HPLC.
`In fact, Fmoc-removal in the presence’ of DBU worsened the effects already ob-
`served in the case of the standard piperidine treatment. However, no significant
`amounts of B-peptide were detected. In the case of OtBu-protection, upon DBUtreat-
`ment an as yet undefined component (5.8%) was observed in addition to the known
`compounds. The OMpe-protecting group showed a significant improvement with re-
`spect to aspartimide formation when compared to regular OtBu-protection. Mostinter-
`estingly, if the Hmb-backbone protection approach was followed, neither under
`standard conditions nor in the presence of DBU,aspartimide orrelated side product
`was observed (detection limit 0.3%).
`
`Conclusions
`This systematic investigation clearly showed that in our test system, no detectable
`amounts of aspartimide were formed if Hmb-backboneprotection wasapplied in addi-
`tion to standard OtBu-protection of the Asp sidé chain. However, the synthesis of all
`different Hmb protected amino acid derivatives followed by their incorporation into
`dipeptides would be quite labourious. Therefore, taking into account the markedly im-
`proved properties of Mpe-protection compared to the standard OtBu-group,this re-
`cently described variant should be considered for sequences prone to aspartimide
`formation.
`
`References
`1. Nicol4s, E., Pedroso, E., Giralt, E. Tetrahedron Lett. 30, 497 (1989).
`2. Offer, J., Quibell, M., Johnson, T. J. Chem. Soc., Perkin Trans. I 175 (1996).
`3. Karlstrém, A., Undén, A. Tetrahedron Lett. 37, 4243 (1996).
`4, Unpublished derivatives.
`
`64
`
`MSN Exhibit 1022 - Page 4 of 4
`MSNv. Bausch - IPR2023-00016
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket